• 240 Citations
  • 9 h-Index
19962019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 3 Similar Profiles
Prostatic Neoplasms Medicine & Life Sciences
Matrix Metalloproteinase Inhibitors Medicine & Life Sciences
Pharmacokinetics Medicine & Life Sciences
Sickle Cell Anemia Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
Squamous Cell Carcinoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

  • 240 Citations
  • 9 h-Index
  • 17 Article
  • 1 Letter

Fasting and Glucose-Stimulated Changes in Plasma Glucagon in Pancreatic Cancer: Potential Biomarkers for Detection?

Stern, J. H., Arriaga, Y. E., Gupta, A., Verma, U., Karri, S., Syed, S. K., Khosama, L., Mansour, J., Meyer, J., Scherer, P. E. & Beg, M. S., Jan 1 2019, In : Pancreas. 48, 1, p. E1-E3

Research output: Contribution to journalLetter

Tumor Biomarkers
Glucagon
Pancreatic Neoplasms
Fasting
Glucose
12 Citations

Phase I, pharmacokinetic and biological correlative study of OSI-7904L, a novel liposomal thymidylate synthase inhibitor, and cisplatin in patients with solid tumors

Ricart, A. D., Berlin, J. D., Papadopoulos, K. P., Syed, S., Drolet, D. W., Quaratino-Baker, C., Horan, J., Chick, J., Vermeulen, W., Tolcher, A. W., Rowinsky, E. K. & Rothenberg, M. L., Dec 1 2008, In : Clinical Cancer Research. 14, 23, p. 7947-7955 9 p.

Research output: Contribution to journalArticle

Thymidylate Synthase
Cisplatin
Pharmacokinetics
Neoplasms
Homocysteine
45 Citations

A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomas

Chu, Q. S. C., Forouzesh, B., Syed, S., Mita, M., Schwartz, G., Copper, J., Curtright, J. & Rowinsky, E. K., Aug 2007, In : Investigational New Drugs. 25, 4, p. 359-367 9 p.

Research output: Contribution to journalArticle

Matrix Metalloproteinase Inhibitors
Sarcoma
Pharmacology
Matrix Metalloproteinases
Disease Progression

Erratum: A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomes (Investigational New Drugs DOI: 10.1007/s10637-006-9031-6)

Chu, Q. S. C., Forouzesh, B., Syed, S., Mita, M., Schwartz, G., Cooper, J., Curtright, J. & Rowinsky, E. K., Aug 2007, In : Investigational New Drugs. 25, 4, p. 357 1 p.

Research output: Contribution to journalArticle

Investigational Drugs
Matrix Metalloproteinase Inhibitors
Pharmacology
tetracycline CMT-3